Annual Cash & Cash Equivalents
$4.89B$1.61B-24.76%
Summary
- Current Value
- As of today, ROIV annual cash & cash equivalents is $4.89B, down -24.76% on
- Historical Performance
- ROIV annual cash & cash equivalents is up +136.85% over the past 3 years, and up +123.71% over the past 5 years
- All-Time High Comparison
- ROIV annual cash & cash equivalents is currently -24.76% below its historical high of $6.50B set on
- 3-Year Low Comparison
- ROIV annual cash & cash equivalents is +190.71% above its 3-year low of $1.68B reached on
- Sector Comparison
- ROIV annual cash & cash equivalents is higher than 98.13% of companies in Healthcare sector
Cash and Cash Equivalents Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $4.89B | -24.8% | +136.8% | +123.7% | +475.5% | |
| Quarterly Cash & Cash Equivalents | $4.39B | -18.6% | +173.7% | +105.8% | +100.8% | |
| Price | $23.44 | +118.3% | +137.5% | +123.9% | – | |
| Annual Current Assets | $5.00B | -25.7% | +132.9% | +125.3% | +321.8% | |
| Annual Total Liabilities | $249.74M | -67.7% | -52.3% | -32.2% | -44.6% | |
| Annual Working Capital | $4.85B | -25.0% | +147.2% | +128.0% | +397.9% | |
| Annual Net Income | -$729.76M | -116.0% | +21.0% | -28.4% | +9.9% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $6.50B | -24.8% | |
| 5Y | $6.50B | -24.8% | |
| All | $6.50B | -24.8% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.68B | +190.7% | |
| 5Y | $1.68B | +190.7% | |
| All | $849.55M | +475.5% |
Cash and Cash Equivalents History
| Year | Value | Change |
|---|---|---|
| $4.89B | -24.8% | |
| $6.50B | +286.4% | |
| $1.68B | -18.5% | |
| $2.06B | -3.2% |
| Year | Value | Change |
|---|---|---|
| $2.13B | -2.4% | |
| $2.19B | +157.3% | |
| $849.55M | - |
FAQ
What is the current annual cash & cash equivalents of ROIV?
As of today, ROIV annual cash & cash equivalents is $4.89B
What is 1-year change in ROIV annual cash & cash equivalents?
ROIV annual cash & cash equivalents is down -24.76% year-over-year
What is 3-year change in ROIV annual cash & cash equivalents?
ROIV annual cash & cash equivalents is up +136.85% over the past 3 years
How far is ROIV annual cash & cash equivalents from its all-time high?
ROIV annual cash & cash equivalents is currently -24.76% below its historical high of $6.50B set on March 31, 2024
How does ROIV annual cash & cash equivalents rank versus sector peers?
ROIV annual cash & cash equivalents is higher than 98.13% of companies in Healthcare sector
When is ROIV next annual earnings release?
As of today, the next annual earnings release for ROIV has not been scheduled
Quarterly Cash & Cash Equivalents
$4.39B$117.32M-2.60%
Summary
- Current Value
- As of today, ROIV quarterly cash & cash equivalents is $4.39B, down -2.60% on
- Historical Performance
- ROIV quarterly cash & cash equivalents is down -18.58% year-over-year, and up +173.74% over the past 3 years
- All-Time High Comparison
- ROIV quarterly cash & cash equivalents is currently -34.27% below its historical high of $6.68B set on
- 3-Year Low Comparison
- ROIV quarterly cash & cash equivalents is +210.40% above its 3-year low of $1.41B reached on
- Sector Comparison
- ROIV quarterly cash & cash equivalents is higher than 97.52% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $4.39B | -2.6% | -18.6% | +173.7% | +105.8% | |
| Annual Cash & Cash Equivalents | $4.89B | – | -24.8% | +136.8% | +123.7% | |
| Price | $23.44 | +44.6% | +118.3% | +137.5% | +123.9% | |
| Quarterly Current Assets | $4.51B | -2.3% | -22.2% | +163.1% | +106.3% | |
| Quarterly Total Liabilities | $257.14M | +18.7% | -58.9% | -63.3% | -51.3% | |
| Quarterly Working Capital | $4.38B | -2.8% | -16.5% | +195.0% | +122.4% | |
| Quarterly Net Income | -$166.04M | +39.4% | +29.9% | +47.4% | +70.5% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $5.15B | N/A | -14.8% |
| 3Y | $6.68B | -34.3% | |
| 5Y | $6.68B | -34.3% | |
| All | $6.68B | -34.3% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $4.39B | at low | |
| 3Y | $1.41B | +210.4% | |
| 5Y | $1.41B | +210.4% | |
| All | $1.41B | +210.4% |
Quarterly Cash & Cash Equivalents History
FAQ
What is the current quarterly cash & cash equivalents of ROIV?
As of today, ROIV quarterly cash & cash equivalents is $4.39B
What is ROIV quarterly cash & cash equivalents most recent change?
ROIV quarterly cash & cash equivalents was down -2.60% on September 30, 2025
What is 1-year change in ROIV quarterly cash & cash equivalents?
ROIV quarterly cash & cash equivalents is down -18.58% year-over-year
How far is ROIV quarterly cash & cash equivalents from its all-time high?
ROIV quarterly cash & cash equivalents is currently -34.27% below its historical high of $6.68B set on December 31, 2023
How does ROIV quarterly cash & cash equivalents rank versus sector peers?
ROIV quarterly cash & cash equivalents is higher than 97.52% of companies in Healthcare sector
When is ROIV next earnings release?
The next earnings release for ROIV is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- ROIV Official Website roivant.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1635088/000163508825000016/0001635088-25-000016-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1635088/000114036125020715/0001140361-25-020715-index.htm
- ROIV Profile on Yahoo Finance finance.yahoo.com/quote/ROIV
- ROIV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/roiv